Gene therapy for radioprotection

Cancer Gene Therapy

Volumn 22, Issue 4, 2015, Pages 172-180

  Everett, W H ^a   Curiel, D T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 1; CATALASE; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 2; HEAT SHOCK PROTEIN 27; INTERLEUKIN 3; KERATINOCYTE GROWTH FACTOR; SUPEROXIDE DISMUTASE; VASCULOTROPIN; ZINC FINGER PROTEIN;

CANCER RADIOTHERAPY; GENE TARGETING; GENE THERAPY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PROTECTION; REVIEW; ANIMAL; GENE EXPRESSION; GENETICS; NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; TRANSGENE;

ANIMALS; GENE EXPRESSION; GENETIC THERAPY; HUMANS; NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; TRANSGENES;

EID: 84928597808     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2015.8     Document Type: Review

References (107)

1. Lawrence TS, Ten Haken RK, Giaccia A. Principles of radiation oncology. In: DeVita VT Jr, Lawrence TS, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 8th edn. Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2008.
2. Hall E, Giaccia A. Radiobiology for the Radiologist, 6th edn. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006.
3. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15: 360-371.
4. Pensado A, Seijo B, Sanchez A. Current strategies for DNA therapy based on lipid nanocarriers. Expert Opin Drug Deliv 2014; 11: 1721-1731.
5. Kaliberov SA, Kaliberova LN, Hong Lu Z, Preuss MA, Barnes JA, Stockard CR et al. Retargeting of gene expression using endothelium specific hexon modified adenoviral vector. Virology 2013; 447: 312-325.
6. Kaliberov SA, Kaliberova LN, Buggio M, Tremblay JM, Shoemak er CB, Curiel DT. Adenoviral targeting using genetically incorporated camelid single variable domains. Lab Invest 2014; 94: 893-905.
7. Akashi M, Hachiya M, Paquette R, Osawa Y, Shimizu S , Suzuki G. Irradiation increases manganese superoxide dismutase mRNA levels in human fibroblasts. J Biol Chem 1995; 270: 15864-15869.
8. Epperly M, Gretton J, Sikora C, Jefferson M, Berna rding M, Nie S et al. Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage. Radiat Res 2003; 160: 568-578.
9. Kang S, Rabbani Z, Folz R, Golson M, Huang H, Yu D et al. Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 2003; 57: 1056-1066.
10. Greenberger J, Epperly M. Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization. In Vivo 2007; 21: 141-146.
11. Dhar S, St. Clair D. Manganese superoxide dismutase regulation and cancer. Free Radic Biol Med 2012; 52: 2209-2222.
12. Epperly M, Bray J, Krager S, Berry L, Gooding W, Engelhardt J et al. Intratracheal injection of ad enovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Rad Onc Biol Phys. 1999; 43: 169-181.
13. Guo H, Wolfe D, Epperly M, Huang S, Liu K, Glorioso J et al. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg 2003; 7: 229-236.
14. Epperly M, Bray J, Kraeger S, Zwacka R, Engelhardt J, Travis E et al. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gen e Therapy 1998; 5: 196-208.
15. Kanai A, Zeidel M, Lavelle J, Greenberger J, Birder L, Groat W et al. Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis. Am J Physiol Renal Physiol 2002; 283: F1304-F1312.
16. Carpenter M, Epperly M, Agarwal A, Nie S, Hricisak L, Niu Y et al. Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradia tion damage. Gene Therapy 2005; 12: 685-693.
17. Epperly M, Smith T, Zhang X, Goff J, Franicola D, Greenberger B et al. Modulation of in utero total body irradiation induced newborn mo use growth retardation by maternal manganese superoxide dismutase-plasmid liposome (MnSOD-PL) gene therapy. Gene Therapy 2011; 18: 579-583.
18. Zhang X, Epperly M, Kay M, Chen Z, Dixon T, Fran icola D et al. Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene. Hum Gene Ther 2008; 19: 820-826.
19. Epperly M, Travis E, Sik ora C, Greenberger J. Magnesium superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-1, TNF-?, and TGF-? correlates with delay of organizing alveolitis/fibrosis. Biol Blood Marrow Transplant 1999; 5: 204-214.
20. Stickle R, Epperly M, Klein E, Bray J, Greenberger J. Prevention of irradiationinduced esophagitis by plasmid/liposome delivery of the human mangan ese superoxide dismutase transgene. Radiat Oncol Invest 1999; 7: 204-217.
21. Eppery M, Kagan V, Sikora C, Gretton J, Defilippi S, Bar-Sagi D et al. Manganese superoxide dismutase-plas mid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int J Cancer 2001; 96: 221-231.
22. Rajagopalan M, Stone B, Rwigema J, Salimi U, Epperl y M, Goff J et al. Intraesophageal manganese superoxide dismutase-plasmid liposomes ameliorates novel total-body and thoracic radiation sensitivity of NOS1?/? mice. Radiat Res 2010; 174: 297-312.
23. Epperly M, Wang H, Jones J, Dixon T, Montesinos C, Greenberger J. Antioxidantchemoprevention diet ameliorates late effects of total-body irradiation and supplements radioprotection by MnSOD-plasmid liposome administration. R adiat Res 2011; 175: 759-765.
24. Epperly M, Carpenter M, Agarwal A, Mitra P, Nie S, Greenberger J. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene the rapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis. In Vivo 2004; 18: 401-410.
25. Epperly M, Wegner R, Kanai A, Kagan V, Greenberger E, Nie S et al. Effects of MnSOD-plasmid liposome gene therapy on antioxidant levels in irradiated murine oral cavity orthotopic tumors. Radiat Res 2007; 167: 289-297.
26. Epperly M, Defilippi S, Sikora C, Gretton J, Kalend A, Greenberger J. Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Therapy 2000; 7: 1011-1018.
27. Zwacka R, Dudus L, Epperly M, Greenberger J, Engelhardt J. Redox gene therapy protects human IB-3 lung epithelial cells against ionizing radiation-induced apoptosis. Hum Gene Ther 1998; 9: 1381-1386.
28. Epperly M, Sikora C, DeFilippi S, Gretton J, Bar-Sagi D, Archer H et al. Pulmonary irradiation-induced expression of VCAM-1 and ICAM-1 is decreased by manganese superoxide dismutase-plasmid/liposome (MnS OD-PL) gene therapy. Biol Blood Marrow Transplant 2002; 8: 175-187.
29. Niu Y, Shen H, Epperly M, Zhang X, Nie S, Cao S et al. Protection of esophageal multi-lineage progenitors of squamous epithelium (stem cells) from ionizing irradiation by manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy. In Vivo 2005; 19: 965-974.
30. Niu Y, Epperly M, Shen H, Smith T, Wang H, Greenberger J. Intraesophageal MnSOD-plasmid liposome enhances engraftment and self-renewal of bone marrow derived progenitors of esophageal squamous epithelium. Gene Therapy 2008; 15: 347-356.
31. Epperly M, Tyurina Y, Nie S, Niu Y, Zhang X, Kagan V et al. MnSOD-plasmid liposome gene therapy decreases ionizing irradiation-induced lipid peroxida tion of the esophagus. In Vivo 2005; 19: 997-1004.
32. Niu Y, Wang H, Wiktor-Brown D, Rugo R, Shen H, Huq M et al. Irradiated esophageal cells are protected from radiation-induced reco mbination by MnSOD gene therapy. Radiat Res 2010; 173: 453-461.
33. Epperly M, Bernarding M, Gretton J, Jefferson M, Nie S, Greenberger J. Overexpression of the transgene for manganese su peroxide dismutase (MnSOD) in 32D cl 3 cells prevents apoptosis induction by TNF?, IL-3 withdrawal, and ionizing radiation. Exp Hematol 2003; 31: 465-474.
34. Epperly M, Smith T, Wang H, Schlesselman J , Franicola D, Greenberger J. Modulation of total body irradiation induced life shortening by systemic intravenous MnSOD-plasmid liposome gene therapy. Radiat Res 2008; 170: 437-443.
35. Epperly M, Melendez J, Zhang X, Nie S, Pearce L, Peterson J et al. Mitochondrial targeting of a catalase transgene product by plasmid liposomes increases radioresistance in vitro and in vivo. Radiat Res 2009; 171: 588-595.
36. Miao W, XuFeng R, Park M, Gu H, Hu L, Kang J et al. Hematopoietic stem cell regeneration enhanced by ectopic expression of ROS-detoxifying enzymes in transplant mice. Mol Therapy 2013; 21: 423-432.
37. Clevers H, Nusse R. Wnt/?-catenin signaling and disease. Cell 2012; 149: 1192-1205.
38. Inagaki-Ohara K, Yada S, Takamura N, Reaves M, Yu X, Liu E et al. P53-dependent radiation-induced crypt intestinal epithelial cells apoptosis is mediated in part through TNF-TNFR1 system. Oncogene 2001; 20: 812-818.
39. Gregorieff A,Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer Genes Dev 2005 19: 877-890.
40. Kim KA, Zhao J, Andarmani S, Kakitani M, Oshima T, Binnerts ME et al. R-Spondin proteins: a novel link to beta-catenin activation. Cell Cycle 2005; 5: 23-26.
41. Nam JS, Turcotte TJ, Smith PF, Choi S, Yoon JK. Mouse cristin/R-spondin family proteins are novel ligands fo r the Frizzled 8 and LRP6 receptors and activate beta-catenin dependent gene expression. J Biol Chem 2006; 281: 13247-13257.
42. Kim KA, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 2005; 309: 1256-1259.
43. Zhao J , de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P et al. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology 2007; 132: 1331-1343.
44. Zhao J, Kim KA, de Vera J, Palencia S, Wagle M, Abo A. R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/?-catenin pathway. Proc Natl Acad Sci USA 2009; 106: 2331-2336.
45. Bhanja P, Saha S, Kabarriti R, Liu L, Roy-Chowdhury N, Roy-Chowdhury J et al. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastro intestinal syndrome in mice. PLoS One009; 4: e8014.
46. Feder ME, Hofmann GE. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu Rev Physiol 1999; 61: 243-282.
47. Lee HJ, Lee YJ, Kwon HC, Bae S, Kim SH, Min JJ et al. Radioprotective effect of heat shock protein 25 on submandibular glands of rats. Am J Pathol 2006; 169: 1601-1611.
48. Lee HJ, Kwon HC, Chung HY, Lee YJ, Lee YS. Recovery from radiation-induced bone marrow damage by HSP25 through Tie2 signaling. Int J Radiat Oncol Biol Phys. 2012; 84: e8 5-e93.
49. Brizel DM, Overgaard J. Does amifostine have a role in chemoradiation treatment? Lancet Oncol 2003; 4: 378-381.
50. Abok K, Brunk U, Jung B, Ericsson J. Morpho logic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B 1984; 45: 443-460.
51. Takagi K, Yamaguchi K, Sakurai T, Asari T, Hashimoto K, Terakawa S. Secretion of saliva in X-irradiated rat submandibular glands. Radiat Res 2003; 159: 351-360.
52. Park SH, Lee SJ, Chung HY, Kim TH, Cho CK, Yoo SY et al. Inducible heat-shock protein 70 is involved in the radioadaptive response. Radiat Res 2000; 153: 318-326.
53. Yi MJ, Park SH, Cho HN, Yong Chung H, Kim JI, Cho CK et al. Heat shock protein 25 (Hspb1) regulates manganese superoxide dismutase through activation of Nfkb (NF-kappaB). Radiat Res 2002; 158: 641-649.
54. Lee YJ, Cho HN, Jeoung DI, Soh JW, Cho CK, Ba e S et al. HSP25 overexpression attenuates oxidative stress-induced apoptosis: roles of ERK1/2 signaling and manganese superoxide dismutase. Free Radic Biol Med 2004; 36: 429-444.
55. Lee YJ, Lee DH, Cho CK, Bae S, Jhon GJ, Lee SJ et al. HSP25 inhibits protein kinase C delta-mediated cell death through direct interaction. J Biol Chem 2005; 280: 18108-18119.
56. Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K et al. Tie2/angiopoietin-signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118: 149-161.
57. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
58. Hesdorffer C, Ayello J, Ward M, K aubisch A, Vahdat L, Balmaceda C et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Onc ol 1998; 16: 165-172.
59. Staley E,Yarbrough V,Schoeb T,Daft J,Tanner S,Steverson D Jr,et al. Murine P-glycoprotein deficiency alters intestinal injury repair and blunt lipopolysacchari de-induced radioprotection Radiat Res 2012 178: 207-216.
60. Maier P, Fleckenstein K, Li L, Laufs S, Zeller W, Baum C et al. Overexpression of MDR1 using a retroviral vector differe ntially regulates genes involved in detoxification and apoptosis and confers radioprotection. Radiat Res 2006; 166: 463-473.
61. Maier P, Herskind C, Fleckenstein K, Spier I, Laufs S, Jens Zell er W et al. MDR1 gene transfer using a lentiviral SIN vector confers radioprotection to human CD34+ hematopoietic progenitor cells. Radiat Res 2008; 169: 301-310.
62. Inoue A, Seidel MG, Wu W, Kamizono S, Ferrando AA, Bronson RT et al. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell 2002; 2: 279-28 8.
63. Maier P, Herskind C, Barzan D, Zeller WJ, Wenz F. SNAI2 as a novel radioprotector of normal tissue by gene transfer using a lentiviral bicistronic SIN vector. Radiat Res 2010; 173: 612-619.
64. Barrallo-Gimeno A, Nieto MA. The snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132: 3151-3161.
65. Metcalf D. Hematopoietic cytokines. Blood 2008; 111: 485-491.
66. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392: 90-93.
67. Dahl C, Hoffmann HJ, Saito H, Schiotz PO. Human mast cells express receptors for IL-3, IL-5 and GM-CSF: a partial map of receptors on human mast cells cultured in vitro. Allergy 2004; 59: 1087-1096.
68. Dentelli P, Del Sorbo L, Rosso A, Molinar A, Garbarino G, Camussi G et al. Human IL-3 stimulates endotheli al cell motility and promotes in vivo new vessel formation. J Immunol 1999; 163: 2151-2159.
69. Eder M, Geissler G, Ganser A. IL-3 in the clinic. Stem Cells 1997; 15: 327-333.
70. Chapel A, Deas O, Bensidhoum M, Francois S, Mouiseddine M, Ponç et P et al. In vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene delivery. Genet Vaccines Ther 2004; 2: 16.
71. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991; 3: 67-85.
72. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-1180.
73. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-641.
74. Hu S, Chen Y, Li L, Chen J, Wu B, Zhou X et al. Effects of adenovirus-mediated delivery of the human hepatocyte growth factor g ene in experimental radiationinduced heart disease. Int J Radiat Oncol Biol Phys. 2005; 75: 1537-1544.
75. Li Q, Sun H, Xiao F, Wang X, Yang Y, Liu Y et al. Protection against radiation induced hematopoietic damage in bone marrow by hepatocyte growth factor gene transfer. Int J Radiat Biol 2014; 90: 36-44.
76. Gao CF, Vade Woude GF. HGF/SF-Met signaling in tumor progression. Cell Res 2005; 15: 49-51.
77. Ribatti D, Vacca A, Rusnati M, Presta M. The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Gr owth Factor Rev 2007; 18: 327-334.
78. Ferrara N, Gerber H, Lecouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
79. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293-297.
80. Cotrim A, Sow ers A, Mitchell J, Baum B. Prevention of irradiation-induced salivary hypofunction by microvessel protection in mouse salivary glands. Mol Ther 2007; 15: 2101-2106.
81. Finch PW, Rubin JS. Ke ratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 2004; 91: 69-136.
82. Shyamsundar M, McAuley DF, In gram RJ, Gibson DS, O'Kane D, McKeown ST. Keratinocyte growth-factor promotes epithelial survival and resolution in a human model of lung injury. Am J Respir Crit Care Med 2014; 189: 1520-1529.
83. Finch PW, Mark Cross LJ, McAuley DF, Farrell CL. Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models. J Cell Mol Med 2013; 17: 1065-1087.
84. Zheng C, Vitolo JM, Zhang W, Mineshiba F, Chiorini JA, Baum BJ. Etended transgene expression from a nonintegratng adenoviral vector containing retroviral elements. Mol Ther 2008; 16: 1089-109 7.
85. Zheng C, Cotrim AP, Sunshine AN, Sugito T, Liu L, Sowers A et al. Prevention of radiation-induced oral mucositis after adenoviral vector-mediated transfer of the keratinocyte growth factor cDNA to m ouse submandibular glands. Clin Cancer Res 2009; 15: 4641-4648.
86. Zheng C, Cotrim AP, Rowzee A, Swaim W, Sowers A, Mitchell JB. Prevention of radiation-induced salivary hypofunction foll owing hKGF gene delivery to murine submandibular glands. Clin Cancer Res 2011; 17: 2842-2851.
87. Finch PW, Rubin JS. Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors. J Natl Cancer Inst 2006; 98: 812-824.
88. Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother 2013; 40: 302-309.
89. Gobe GC, Morais C, Vesey DA, Johnson DW. Use of high-dose erythropoietin for repair after injury: a comparison of outcomes in heart and kidney. J Nephropathol 2013; 2: 154165.
90. Kaka vas S, Demestiha T, Vasileiou P, Xanthos T. Erythropoetin as a novel agent with pleiotropic effects against acute lung injury. Eur J Clin Pharmacol 2011; 67: 1-9.
91. Rocha EM, Cotrim AP, Zheng C, Riveros PP, Baum BJ, Chiorini JA. Recovery of radiation-induced dry eye and corneal damage by pretreatment with adenoviral vector-mediated transfer of erythropoietin to the salivary glands in mice. Hum Gene Ther 2013; 24: 417-423.
92. Agre P, King LS, Yasui M, Guggino WB, Ottersen OP, Fujiyoshi Y et al. Aquaporin water channels-from atomic structure to clinical medicine. J Physiol 2002; 542: 3-16.
93. Baum BJ, Zheng C, Cotrim AP, McCullagh L, Goldsmith CM, Brahim JS et al. Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. Handb Exp Pharmacol 2009; 190: 403-418.
94. Delporte C, O'Connell BC, He X, Lancaster HE, O'Connell AC, Agre P. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glan ds. Proc Natl Acad Sci USA 1997; 94: 3268-3273.
95. Shan Z, Li J, Zheng C, Liu X, Fan Z, Zhang C et al. Increased fluid secretion after adenoviral-mediated transfer of the human aquapo rin-1 cDNA to irradiated miniature pig parotid glands. Mol Ther 2005; 11: 444-451.
96. Zheng C, Goldsmith CM, Mineshiba F, Chiorini JA, Kerr A, Wenk ML et al. Toxicity and biodistribut ion of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. Hum Gene Ther 2006; 17: 1122-1133.
97. Baum BJ, Alevizos I, Zh eng C, Cotrim AP, Liu S, McCullagh L et al. Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci USA 2012; 109: 19403-19407.
98. Gao R, Yan X, Zheng C, Goldsmith CM, Afione S, Hai B et al. AAV2-mediated transfer of the human aquaporin-1 cDNA restores fluid secretion from irradiated miniature pig parotid glands. Gene Therapy 2 011; 18: 38-42.
99. Michelfelder S, Trepel M. Adeno-Associated viral vectors and their redirection to cell-type specific receptors. Adv Genet 2009; 67: 29-60.
100. Beatty M, Curiel DT. Chapter two-Adenovirus strategies for tissue-specific targeting. Adv Cancer Res 2012; 115: 39-67.
101. Alberti MO, Roth JC, Ismail M, Tsuruta Y, Abraham E, Pereboe va L et al. Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation. PLoS One 2012; 7: e37812.
102. Rajendran S,O'Sullivan GC,O'Hanlon D,Tangney M. Adenovirus-mediated transcriptional targeting of colorectal cancer and effects on treatment-resistant hypoxic cells Clin Colorectal Cancer 2013 12, 152-162.
103. Sugio K, Sakurai F, Katayama K, Tashiro K, Matsui H, Kawabata K et al. Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporation of normal cell-specific microRNA-targeted sequences. Clin Cancer Res 2011; 17: 2807-2818.
104. Corso CD, Ali AN, Diaz R. Radiation-induced tumor neoantigens: imaging and therapeutic implications. Am J Cancer Res 2011; 1: 390-412.
105. Rashi-Elkeles S, Elkon R, Shavit S, Lerenthal Y, Linhart C, Kupershtein A et al. Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol Oncol 2011; 5: 336-348.
106. Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev 2013; 23: 12-19.
107. Sun NF, Liu ZA, Huang WB, Tian AL, Hu SY. The research of nanoparticles as gene vector for tumor gene therapy. Crit Rev Oncol Hematol 2014; 89: 352-357.